Evidence map›Paper›PMID 36203943›Full record

ArticlePreventive medicine reports2022

The design and development of an encounter tool to support shared decision making about preventing cardiovascular events.

Sandra A Hartasanchez, Ian G Hargraves, Jennifer E Clark, Derek Gravholt, Juan P Brito, Megan E Branda, Yvonne L Gomez, Vivek Nautiyal, Charanjit S Khurana, Randal J Thomas and 2 more

Abstract read
In one paragraph

Article in Preventive medicine reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Association between Exposure to Statin Choice and Adherence to Statins: An Observational Cohort Study.Medical decision making : an international journal of the Society for Medical Decision Making · 2025
    Observational
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sandra A HartasanchezKnowledge and Evaluation Research Unit, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Ian G HargravesKnowledge and Evaluation Research Unit, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Jennifer E ClarkKnowledge and Evaluation Research Unit, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Derek GravholtKnowledge and Evaluation Research Unit, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Juan P BritoKnowledge and Evaluation Research Unit, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Megan E BrandaKnowledge and Evaluation Research Unit, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Yvonne L GomezAltru Health System, 1380 S. Columbia Road, Grand Forks, ND 58206, USA.
Vivek NautiyalWellstar Center for Cardiovascular Care, 55 Whitcher Street, NE, Suite 350, Marietta, GA 30060, USA.
Charanjit S KhuranaVirginia Hospital Center Physician Group-Cardiology, 1715 North George Mason Drive, Arlington, VA 22205, USA.
Randal J ThomasDivision of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Victor M MontoriKnowledge and Evaluation Research Unit, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Jennifer L RidgewayKnowledge and Evaluation Research Unit, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Funding

Implementing Shared Decision Making (SDM) for Individualized CV Prevention (SDM4IP)R01HL151662 · NHLBI · MAYO CLINIC ROCHESTER · PI MONTORI, VICTOR MANUEL, RIDGEWAY, JENNIFER L · 2020 to 2023
$2.7M
NHLBI NIH HHS R01 HL151662
6 · The paper itself

Abstract

Patients at high risk for cardiovascular disease (CVD) tend to receive less intensive preventive care. Clinical practice guidelines recommend shared decision making (SDM) to improve the quality of primary CVD prevention. There are tools for use during the clinical encounter that promote SDM, but, to our knowledge, there are no SDM encounter tools that support conversations about available lifestyle and pharmacological options that can lead to preventive care that is congruent with patient goals and CVD risk. Using the best available evidence and human-centered design (iterative design in the context of ultimate use with users), our team developed a SDM encounter tool, CV Prevention Choice. Each subsequent version during the iterative development process was evaluated in terms of content, usefulness, and usability by testing it in real preventive encounters. The final version of the tool includes a calculator that estimates the patient's risk of a major atherosclerotic CVD event in the next 10 years. Lifestyle and medication options are presented, alongside their pros, cons, costs, and other burdens. The risk reduction achieved by the selected prevention program is then displayed to support collaborative deliberation and decision making. A U.S. multicenter trial is estimating the effectiveness of CV Prevention Choice in achieving risk-concordant CV prevention while identifying the best strategies for increasing the adoption of the SDM encounter tool and its routine use in practice.

Indexed as

Cardiovascular disease preventionDecision aidsEncounter toolsShared decision making

Identifiers

PMID36203943
PMCPMC9530931

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.